<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Kazan medical journal</journal-id><journal-title-group><journal-title xml:lang="en">Kazan medical journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Казанский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0368-4814</issn><issn publication-format="electronic">2587-9359</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">80536</article-id><article-id pub-id-type="doi">10.17816/kazmj80536</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">On the issue of subcutaneous use of pilocarpine in postoperative urinary retention</article-title><trans-title-group xml:lang="ru"><trans-title>К вопросу о подкожном применении пилокарпина при послеоперационной задержки мочеиспускания</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Belitz</surname><given-names>O.</given-names></name><name xml:lang="ru"><surname>Белиц</surname><given-names>О.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>info@eco-vector.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff id="aff1"><institution></institution></aff><pub-date date-type="pub" iso-8601-date="1932-04-15" publication-format="electronic"><day>15</day><month>04</month><year>1932</year></pub-date><volume>32</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>339</fpage><lpage>343</lpage><history><date date-type="received" iso-8601-date="2021-09-19"><day>19</day><month>09</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-09-19"><day>19</day><month>09</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2021, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2021, Эко-Вектор</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://kazanmedjournal.ru/kazanmedj/article/view/80536">https://kazanmedjournal.ru/kazanmedj/article/view/80536</self-uri><abstract xml:lang="en"><p>Postoperative, as well as postpartum ischuria is a very unpleasant complication, since all commonly used means are heat to the bladder, instillation of 10% boric glycerin into the bladder (Corbineau method), liq. kalii acetici per os, injections of 1.0-2.0 25% magnesiae sulfur, under the skin (Voytashevsky method), intravenous injections of 5.0-10.0 40% urotropin (according to V o g t'y) - often give refusal or induce urination after many hours and thus force the use of a catheter. As for catheterization, this method is recognized as fraught with complications and should be used, according to Dieterichs, only as an ultimum refugium.</p></abstract><trans-abstract xml:lang="ru"><p>Послеоперационная, равно как и послеродовая ишурия представляет собою очень неприятное осложнение, так как все обычно применяемые при этом средства—тепло на мочевой пузырь, инстилляции 10% борного глицерина в пузырь (метод Сorbineau), liq. kalii acetici per os, инъекции 1,0—2,0 25% magnesiae sulfur, под кожу (метод Войта­шевского), внутривенные инъекции 5,0—10,0 40% уротропина (по V о g t’y)—нередко дают отказ или же вызывают мочеиспускание через много часов и, таким образом, принуждают прибегать к катетеру. Что же касается катетеризации, то этот способ признается всеми чреватым осложнениями и должен быть применяем, по словам Дитерихса, лишь как ultimum refugium.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Kazan Medical archive</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>Казанский медицинский архив</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list/></back></article>
